Navigation Links
BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards

Francisco Gonzlez, chairman of BBVA, today presented the BBVA Foundation Frontiers of Knowledge Awards. The prize money in these new BBVA Foundation Awards (an annual 3.2 million euros) and the breadth of scientific and artistic disciplines addressed place them among the worlds major awards, second only to the Nobel Prize.

In his presentation speech, Francisco Gonzlez affirmed that these awards will honor excellence in research and artistic creation, with an accent on forward-looking projects that address the major challenges confronting the global society of the 21st century.

We also wish to activate societys latent regard for the work of the scientific community, the BBVA Chairman continued, and believe the BBVA Foundation Frontiers of Knowledge Awards are an effective means to do so.

In sum, he concluded, the awards we are launching here will stand as a new international benchmark, as well as marking a qualitative leap in BBVAs support for knowledge and innovation.

The BBVA Chairman also remarked in this speech that our engagement with society, our vision of corporate social responsibility have led us to devote growing resources both human and financial to the generation and spread of knowledge; this philosophy of the BBVA Group and its foundations, both in Spain and Latin America, is what lies behind initiatives like these Awards, which will stand as a benchmark for scientists and creative practitioners, while providing recognition and encouragement to the many people and teams all round the world who are working, like BBVA, to achieve a better future for humanity.

The BBVA Foundation chairman was joined at the event by Carlos Martnez, president of Spains principal public research organization, the Consejo Superior de Investigaciones Cientficas, which will collaborate in the appointment of technical evaluation committees and propose the chairs of the prize juries.


The BBVA Foundation Frontiers of Knowledge Awards seek to recognize and encourage research and artistic creation, prizing contributions of lasting impact for their originality, theoretical and conceptual implications and, where appropriate, their translation to innovative practices of a salient nature.

The name of the scheme is intended to encapsulate both research work that successfully enlarges the scope of our current knowledge, continually pushing forward the frontiers of the known world, and the meeting of different disciplinary areas. Oriented to the branches of knowledge that most characterize the 21st century, the BBVA Foundation Awards wish to recognize the emergence of new knowledge areas, along with the interdisciplinary nature of scientific research and the fact that many seminal contributions to our current stock of knowledge are the result of collaborative working between large and frequently multinational research teams.


These awards will honor disciplinary or interdisciplinary advances in a series of basic, natural, social and technological sciences, along with creative activity of excellence in the arts. Categories are also reserved for two core concerns of early 21st century society, namely climate change and development cooperation, with awards going alternatively to outstanding research work or projects that mark a significant advance in addressing these global challenges.

The BBVA Foundation Frontiers of Knowledge Awards, to be given annually, take in the following categories:

  • Basic Sciences (Physics, Chemistry, Mathematics)
  • Biomedicine
  • Ecology and Conservation Biology
  • Information and Communication Technology
  • Economics, Finance and Business Management
  • Arts (Music, Painting, Sculpture, Architecture)
  • Climate Change
  • Development Cooperation


The BBVA Foundation Frontiers of Knowledge Awards come with a monetary award of 400,000 euros in each prize category. This is higher than both the global and individual amounts per category of such prestigious international schemes as the Kyoto, Wolf, Kavli or Japan prizes:

  • Nobel Prize (annual): 6 million euros with 1 million per category
  • BBVA Foundation Awards (annual): 3.2 million euros with 400,000 per category
  • Kavli Prize (biennial): 2.1 million euros with 700,000 per category
  • Kyoto Prize (annual): 900,000 euros with 300,000 per category
  • Japan Prize (annual): 600,000 euros with 300,000 per category
  • Wolf Prize (annual): 407,280 euros with 67,880 per category


The scientific community receives little in the way of explicit or symbolic recognition, despite the fact that scientists number among the professional groups most highly valued by society. The BBVA Foundation Frontiers of Knowledge Awards aim to activate this latent regard on the part of society for scientists and their work.

The Foundations desire to publicly recognize the efforts of researchers, organizations and professionals working to improve the societies where they operate has found previous expression in the BBVA Foundation Awards for Biodiversity Conservation, which will be incorporated within the Frontiers of Knowledge scheme following the conclusion of their third edition, the Giner de los Ros Awards for the Improvement of Educational Quality organized jointly with the Spanish Ministry for Education and Science since 1983 and the Economics for Management Lecture Series award of the BBVA Foundation and IESE.

In this respect, the BBVA Foundation expresses the engagement of BBVA with the cause of social responsibility in the societies where it does business, placing knowledge and innovation at the service of a better quality of life for citizens.


Contact: Javier Fernndez
Fundacin BBVA

Related medicine news :

1. Meth Project Chairman Testifies Before U.S. Senate Finance Committee
2. MGT Chairman and CEO Buys 250,000 MGT shares
3. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
4. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
7. Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2, 2007
8. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
9. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
10. Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families
11. Avicena Appoints Dr. Belinda Tsao-Nivaggioli as Chairman of the Board of Directors
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: